Changing Healthcare Worldwide

Kenneth B. Kirby

President & Chief Executive Officer

Kenneth B. Kirby is the President and CEO for TDSC. Mr. Kirby has been pioneering in transdermal delivery since 1990 and oversees both operations and technical development. He is the co-inventor of the TDSC technology.

In 2001, Mr. Kirby formed the Langford Research Institute and started a fully funded academic and research collaboration with the William Harvey Research Institute at St. Bartholomew’s and Queen Mary’s Medical College, University of London. Mr. Kirby has personally directed the preclinical and clinical research efforts with the Harvey encompassing 19 trials of 17 varied compounds and 7 human trials. Mr. Kirby received a B.A. in pre-medical studies from Florida State University. He is a member of Phi Beta Kappa and the American Chemical Society.